ClinicalTrials.gg
RecruitingNCT07794332PePsAdoTNDUpdated Aug 31, 2026

Symptom Assessment in Adolescents Placed on Child Welfare

An observational study in Complex Post-Traumatic Stress Disorder (CPTSD), Borderline Personality Disorder (BPD) and Post-Traumatic Stress Disorder, PTSD, sponsored by University Hospital, Strasbourg, France. Recruiting at 1 site in France. Open to participants aged 12 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-08-31.

Sponsored by University Hospital, Strasbourg, France · Observational

From the registry’s dates

  • Started Jan 2026; still recruiting 9 months later.
Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
200
Ages
12 Years to 18 Years
Sex
All
01

Study summary

This study aims to characterize emotional dysregulation in complex post-traumatic stress disorder (cPTSD) and to determine the extent to which it can promote the distinction with borderline personality disorder (BPD) and post-traumatic stress disorder (PTSD).

As emotional dysregulation is a dynamic process whose phenomenological manifestations are labile, associated with physiological modifications and modulated by cognitive processing, a multiple methodology associating measurements in a real-life ecological context with measurements performed in the hospital will be preferred.

Overall, this study proposes to capture, for the first time, the clinical manifestations associated with cPTSD from the perspective of emotional dysregulation and its underlying processes

02

Conditions studied

  • Complex Post-Traumatic Stress Disorder (CPTSD)
  • Borderline Personality Disorder (BPD)
  • Post-Traumatic Stress Disorder, PTSD
03

In context

Borderline Personality Disorder

278 studies on the registry are indexed under Borderline Personality Disorder; 70 are open to participants now.

This study's planned enrollment of 200 is above the median of 91 across 44 observational studies indexed under Borderline Personality Disorder.

Browse Borderline Personality Disorder studies →

Lead sponsor

University Hospital, Strasbourg, France is the lead sponsor of 999 studies on the registry; 358 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
12 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

a population of adolescents recently placed at the Bas-Rhin ASE

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adolescent aged 12 to 17
  • Entrusted to ASE Bas-Rhin.
  • Fluent in French
  • Affiliated with a social health insurance scheme
  • Agreeing to take part in the study
  • Legal representative of the minor or his/her guardian, or his/her representative from the ASE agreeing to take part in the study.

Exclusion criteria

Exclusion Criteria:

  • Adolescent refusing to participate in the study
  • Legal representative of the minor or his/her guardian, or his/her ASE representative refusing to participate in the study
  • Adolescent with severe developmental delay
  • Adolescent participating in another research study
  • Adolescent deprived of liberty by judicial or administrative decision
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
200 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Prevalence of post-traumatic stress disorder (PTSD) according to Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria

    PTSD will be assessed according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) diagnostic criteria, using the Child Post-Traumatic Checklist (CPC-P). The outcome will be the proportion of participants meeting DSM-5 diagnostic criteria for PTSD.

    Time frame: From inclusion to the end (6 months)

  2. Prevalence of complex post-traumatic stress disorder (CPTSD) according to International Classification of Diseases, 11th Revision (ICD-11) criteria

    Complex post-traumatic stress disorder (CPTSD) will be assessed according to the International Classification of Diseases, 11th Revision (ICD-11) diagnostic criteria, using the Child and Adolescent Trauma Screen (CATS). The outcome will be the proportion of participants meeting ICD-11 diagnostic criteria for CPTSD.

    Time frame: From inclusion to 6 months

07

Study locations

1 of 1 sites recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 31, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07794332
Responsible party
Sponsor
First posted
Aug 31, 2026
Start date
Jan 30, 2026
Primary completion
Sep 1, 2027 (estimated)
Completion
Mar 1, 2028 (estimated)
Last update
Aug 31, 2026

Study contacts

Carmen SCHRÖDER
Contact
carmen.schroder@chru-strasbourg.fr
0033388115248

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion